- KASL clinical practice guidelines: management of hepatitis C
-
The Korean Association for the Study of the Liver (KASL)
- KMID: 2363030
- Clin Mol Hepatol.
- 2016 Mar;22(1):76-139.
- doi: 10.3350/cmh.2016.22.1.76
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- KASL clinical practice guidelines: Management of Hepatitis C
-
The Korean Association for the Study of the Liver (KASL)
- KMID: 1788561
- Clin Mol Hepatol.
- 2014 Jun;20(2):89-136.
- doi: 10.3350/cmh.2014.20.2.89
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Predictors of spontaneous viral clearance and outcomes of acute hepatitis C infection
-
Cho YK, Kim YN, Song BC
- KMID: 2070255
- Clin Mol Hepatol.
- 2014 Dec;20(4):368-375.
- doi: 10.3350/cmh.2014.20.4.368
BACKGROUND/AIMS: This study evaluated the predictors of spontaneous viral clearance (SVC), as defined by two consecutive undetectable hepatitis C virus (HCV) RNA tests performed > or =12 weeks apart, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Factors Associated with HIV-1 Proviral DNA Loads in Patients with Undetectable Plasma RNA Load
-
Choi JY, Song YG, Kim YH, Kim CO, Kim MS, Chin BS, Han SH, Choi SH, Lee HS, Jeong SJ, Choi H, Kim JM
- KMID: 1794422
- J Korean Med Sci.
- 2009 Feb;24(1):152-154.
- doi: 10.3346/jkms.2009.24.1.152
To evaluate factors associated with human immunodeficiency virus type 1 (HIV-1) proviral DNA load, we conducted a cross-sectional study of 36 chronically HIV-1- infected individuals with undetectable plasma viral RNA.... -
- CITED
-
- Close
- SHARE
-
- Close
- Membranoproliferative glomerulonephritis associated with HCV infection in native kidneys and renal allograft
-
Jeong HJ, Choi KH, Chon CY, Kim SI, Park K
- KMID: 1038451
- J Korean Med Sci.
- 1998 Dec;13(6):670-675.
- doi: 10.3346/jkms.1998.13.6.670
Hepatitis C viral infection occurs relatively low in Korea compared to hepatitis B. However, it progresses into chronic hepatitis and cirrhosis more frequently than HBV. It may be associated... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of ARCHITECT HCV Core Antigen Assay
-
Song D, Kang JE, Kim SY, Hwang SH, Kim HH, Lee EY, Son HC
- KMID: 1781673
- Korean J Lab Med.
- 2010 Dec;30(6):654-659.
- doi: 10.3343/kjlm.2010.30.6.654
BACKGROUND: Hepatitis C virus (HCV) core antigen (Ag) levels are known to be well correlating with HCV RNA levels, and may be used as an alternative marker of HCV replication... -
- CITED
-
- Close
- SHARE
-
- Close
- Barriers to treatment of failed or interferon ineligible patients in the era of DAA: single center study
-
Seo KI, Yun BC, Li WJ, Lee SU, Han BH, Park ET
- KMID: 2412117
- Clin Mol Hepatol.
- 2017 Mar;23(1):74-79.
- doi: 10.3350/cmh.2016.0052
BACKGROUND/AIMS: Interferon-based treatment is not appropriate for a large number of patients with chronic hepatitis C for various medical and social reasons. Newly developed directly acting antivirals (DAAs) have been... -
- CITED
-
- Close
- SHARE
-
- Close
- Monitoring antibody titers to recombinant Core-NS3 fusion polypeptide is useful for evaluating hepatitis C virus infection and responses to interferon-alpha therapy
-
Park YM, Byun BH, Choi JY, Bae SH, Kim BS, So HS, Ryu WS
- KMID: 648075
- J Korean Med Sci.
- 1999 Apr;14(2):165-170.
- doi: 10.3346/jkms.1999.14.2.165
To evaluate the clinical feasibility of the antibody titer against a chimeric polypeptide (named Core 518), in which a domain of Core and NS3 of hepatitis C virus (HCV) was... -
- CITED
-
- Close
- SHARE
-
- Close
- The relationship between virological characteristics of hepatitis C virus (HCV) and reactivity to the regional specific proteins of HCV
-
Yoon SK, Park YM, Byun BH, Bae SH, Yang JM, Ahn BM, Lee YS, Lee CD, Sun HS, Kim BS
- KMID: 759502
- Korean J Intern Med.
- 2000 Jul;15(2):109-116.
BACKGROUND: Although the polyproteins of hepatitis C virus(HCV) are processed and formed in nearly equimolar amounts, individual functional proteins have a discrepancy... -
- CITED
-
- Close
- SHARE
-
- Close
- 24 Weeks Treatment with Pegylated Interferon Alfa Plus Ribavirin May Be Possible in Genotype 1 Chronic Hepatitis C Patients with Rapid Virological Response Who Have Low Pretreatment Viremia
-
Moon SS, Kang HG, Seo JA, Jung EU, Lee SH, Park SJ, Lee YJ, Seol SY
- KMID: 1775876
- Korean J Gastroenterol.
- 2010 Jul;56(1):33-38.
- doi: 10.4166/kjg.2010.56.1.33
BACKGROUND/AIMS: The standard treatment for chronic hepatitis C infected with hepatitis C virus (HCV) genotype 1 is a combination of pegylated interferon alfa and ribavirin over a 48 weeks period.... -
- CITED
-
- Close
- SHARE
-
- Close
- The CD4 slope can be a predictor of immunologic recovery in advanced HIV patients: a case-control study
-
Kim KH, Yi J, Lee SH
- KMID: 2381569
- Korean J Intern Med.
- 2015 Sep;30(5):705-713.
- doi: 10.3904/kjim.2015.30.5.705
BACKGROUND/AIMS: Advanced human immunodeficiency virus (HIV) infection, despite sustained viral suppression by highly active antiretroviral therapy (HAART), is a risk factor for poor immunologic recovery. However, some patients with advanced... -
- CITED
-
- Close
- SHARE
-
- Close
- A Study on Viral Hepatitis Markers and Abnormal Liver Function Test in Adults Living in Northwest Area of Chungnam
-
Kim SB, Lee WK, Choi H, Kim SM, Noh R, Kang HY, Lee SS, Ra SS, Gong JH, Shin HD
- KMID: 1792752
- Korean J Gastroenterol.
- 2009 Jun;53(6):355-360.
- doi: 10.4166/kjg.2009.53.6.355
BACKGROUND/AIMS: We studied the prevalence of chronic hepatitis B, C and abnormality on liver function among the population in northwest area of Chungnam. METHODS: We have reviewed 40,112 adults who... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of the reverse transcription-PCR with the branched DNA assay for measurement of human immunodeficiency virus type 1 RNA levels in plasma of Korean patients
-
Won DI, Park JY, Kim JM, Kim HS
- KMID: 720609
- Yonsei Med J.
- 2001 Apr;42(2):204-208.
- doi: 10.3349/ymj.2001.42.2.204
Viral load testing of human immunodeficiency virus (HIV) is an essential tool for initiating and monitoring the antiretroviral therapy for HIV patients. To this end, several methods... -
- CITED
-
- Close
- SHARE
-
- Close
- A Polymorphism in the Microsomal Triglyceride Transfer Protein Can Predict the Response to Antiviral Therapy in Egyptian Patients with Chronic Hepatitis C Virus Genotype 4 Infection
-
Saad Y, Shaker O, Nassar Y, Ahmad L, Said M, Esmat G
- KMID: 2070084
- Gut Liver.
- 2014 Nov;8(6):655-661.
- doi: 10.5009/gnl13374
BACKGROUND/AIMS: A polymorphism in the microsomal triglyceride transfer protein (MTP) is associated with hepatic fibrosis, and carriers showed higher levels of steatosis, higher levels of hepatitis C virus (HCV) RNA... -
- CITED
-
- Close
- SHARE
-
- Close
- Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection
-
Kim JM, Lee KW, Song GW, Jung BH, Lee HW, Yi NJ, Kwon CD, Hwang S, Suh KS, Joh JW, Lee SK, Lee SG
- KMID: 2373137
- Clin Mol Hepatol.
- 2016 Sep;22(3):366-371.
- doi: 10.3350/cmh.2016.0022
BACKGROUND/AIMS: The relationship between patient survival and biopsy-proven acute rejection (BPAR) in liver transplant recipients with hepatitis C remains unclear. The aims of this study were to compare the characteristics... -
- CITED
-
- Close
- SHARE
-
- Close
- Expression of Transforming Growth Factor beta-1 in Chronic Hepatitis and Hepatocellular Carcinoma Associated with Hepatitis C Virus Infection
-
Kim HG, Chung YH, Song BC, Kim JA, Yang SH, Lee YS, Suh DJ
- KMID: 759514
- Korean J Intern Med.
- 2000 Dec;15(3):165-170.
BACKGROUND: Transforming growth factor beta-1 (TGF beta 1) has been suggested to play a role in the development, growth or progression of hepatocellular carcinoma (HCC). Genotype and serum titer of... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of daclatasvir and asunaprevir for hepatitis C virus genotype 1b infection
-
Nam HC, Lee HL, Yang H, Song MJ
- KMID: 2373122
- Clin Mol Hepatol.
- 2016 Jun;22(2):259-266.
- doi: 10.3350/cmh.2016.0020
BACKGROUND/AIMS: The treatment strategy for hepatitis C virus (HCV) has been changing rapidly since the introduction of direct-acting antivirals such as daclatasvir (DCV) and asunaprevir (ASV). We evaluated the efficacy... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of daclatasvir plus asunaprevir for Korean patients with HCV genotype Ib infection: a retrospective multi-institutional study
-
Cho BW, Kim SB, Song IH, Lee SH, Kim HS, Lee TH, Kang YW, Kim SH, Lee BS, Chae HB
- KMID: 2412114
- Clin Mol Hepatol.
- 2017 Mar;23(1):51-56.
- doi: 10.3350/cmh.2016.0053
BACKGROUND/AIMS: The combination of daclatasvir (DCV) and asunaprevir (ASV) has demonstrated a high sustained virologic response at 12 weeks (SVR12) and a low rate of adverse events in previous clinical... -
- CITED
-
- Close
- SHARE
-
- Close
- Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in Korea
-
Cho Y, Cho EJ, Lee JH, Yu SJ, Yoon JH, Kim YJ
- KMID: 2359817
- Clin Mol Hepatol.
- 2015 Dec;21(4):358-364.
- doi: 10.3350/cmh.2015.21.4.358
BACKGROUND/AIMS: The previous standard treatment for chronic hepatitis C (CHC) patients, comprising a combination of pegylated interferon (IFN) and ribavirin, was associated with suboptimal efficacy and severe adverse reactions. A... -
- CITED
-
- Close
- SHARE
-
- Close
- Distribution of hepatitis C virus genotypes in Jeju Island
-
Lee H, Cho YK, Kim HU, Choi EK, Hyun S, Kang D, Jeong SU, Kim HJ, Kim KS, Song BC
- KMID: 1073327
- Korean J Hepatol.
- 2008 Mar;14(1):28-35.
- doi: 10.3350/kjhep.2008.14.1.28
BACKGROUNDS/AIMS: The hepatitis C virus (HCV) genotype affects clinical outcomes of HCV infection, in terms of the response to antiviral therapy and progression of chronic liver diseases, and shows... -
- CITED
-
- Close
- SHARE
-
- Close
